American International Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-18,705
| Closed | -$705 | – | 3405 |
|
|
2021
Q1 | $705 | Buy |
18,705
+508
| +3% | +$12.7K | ﹤0.01% | 1652 |
|
|
2020
Q4 | $310 | Buy |
18,197
+2,182
| +14% | +$27.3K | ﹤0.01% | 2032 |
|
|
2020
Q3 | $75K | Sell |
16,015
-365
| -2% | -$1.85K | ﹤0.01% | 2689 |
|
|
2020
Q2 | $100K | Sell |
16,380
-3,810
| -19% | -$15.7K | ﹤0.01% | 2541 |
|
|
2020
Q1 | $46K | Sell |
20,190
-1,167
| -5% | -$4.95K | ﹤0.01% | 2718 |
|
|
2019
Q4 | $98K | Sell |
21,357
-411
| -2% | -$1.63K | ﹤0.01% | 2639 |
|
|
2019
Q3 | $84K | Buy |
21,768
+278
| +1% | +$1.52K | ﹤0.01% | 2707 |
|
|
2019
Q2 | $130K | Buy |
21,490
+104
| +0.5% | +$994 | ﹤0.01% | 2513 |
|
|
2019
Q1 | $287K | Sell |
21,386
-693
| -3% | -$7.9K | ﹤0.01% | 2012 |
|
|
2018
Q4 | $205K | Sell |
22,079
-170
| -0.8% | -$2.02K | ﹤0.01% | 2172 |
|
|
2018
Q3 | $310K | Buy |
22,249
+628
| +3% | +$9.34K | ﹤0.01% | 2154 |
|
|
2018
Q2 | $342K | Buy |
21,621
+595
| +3% | +$10.4K | ﹤0.01% | 2061 |
|
|
2018
Q1 | $361K | Buy |
21,026
+2,714
| +15% | +$52.9K | ﹤0.01% | 1919 |
|
|
2017
Q4 | $401K | Buy |
18,312
+86
| +0.5% | +$2.77K | ﹤0.01% | 1911 |
|
|
2017
Q3 | $746K | Buy |
18,226
+1,363
| +8% | +$42.8K | ﹤0.01% | 1524 |
|
|
2017
Q2 | $508K | Buy |
16,863
+249
| +1% | +$7.77K | ﹤0.01% | 1694 |
|
|
2017
Q1 | $601K | Buy |
16,614
+1,100
| +7% | +$48.5K | ﹤0.01% | 1478 |
|
|
2016
Q4 | $777K | Sell |
15,514
-41
| -0.3% | -$2.15K | ﹤0.01% | 1375 |
|
|
2016
Q3 | $816K | Buy |
15,555
+23
| +0.1% | +$1.1K | ﹤0.01% | 1330 |
|
|
2016
Q2 | $642K | Buy |
15,532
+1,585
| +11% | +$68.9K | ﹤0.01% | 1441 |
|
|
2016
Q1 | $567K | Hold |
13,947
| – | – | ﹤0.01% | 1919 |
|
|
2015
Q4 | $579K | Buy |
13,947
+978
| +8% | +$32.8K | ﹤0.01% | 1918 |
|
|
2015
Q3 | $199K | Buy |
12,969
+15
| +0.1% | +$322 | ﹤0.01% | 2839 |
|
|
2015
Q2 | $322K | Buy |
12,954
+1,764
| +16% | +$39.3K | ﹤0.01% | 2582 |
|
|
2015
Q1 | $256K | Buy |
11,190
+350
| +3% | +$8.83K | ﹤0.01% | 2736 |
|
|
2014
Q4 | $293K | Sell |
10,840
-430
| -4% | -$7.4K | ﹤0.01% | 2616 |
|
|
2014
Q3 | $132K | Sell |
11,270
-7
| -0.1% | -$88 | ﹤0.01% | 3320 |
|
|
2014
Q2 | $175K | Buy |
11,277
+7,457
| +195% | +$107K | ﹤0.01% | 3108 |
|
|
2014
Q1 | $75.1K | Buy |
3,820
+92
| +2% | +$1.56K | ﹤0.01% | 3630 |
|
|
2013
Q4 | $62.6K | Buy |
+3,728
| New | +$46.3K | ﹤0.01% | 3665 |
|
American International Group's FPRX Position: Q2 2021 in Review
American International Group sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 18,705 shares — an estimated $705 sold.
American International Group first reported a position in FPRX in Q4 2013 and held it in 30 quarters. The position peaked at $816K in Q3 2016. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- American International Group reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- American International Group sold 18,705 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $705.
- American International Group first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 30 quarters.
- American International Group's Five Prime Therapeutics, Inc. position peaked at $816K in Q3 2016.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.